MPM BIOVENTURES 2018, L.P. - 10%+ Owner at Aktis Oncology, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
AKTS on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by MPM BIOVENTURES 2018, L.P. since 12 Mar 2025

Holdings reported by MPM BIOVENTURES 2018, L.P. for Aktis Oncology, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 10,260,064 $219,052,366 $21.35 12 Jan 2026 Indirect
Series A Redeemable Convertible Preferred Stock 0 12 Jan 2026 Indirect Common Stock
Series B Redeemable Convertible Preferred Stock 0 12 Jan 2026 Indirect Common Stock
Series Seed Redeemable Convertible Preferred Stock 0 12 Jan 2026 Indirect Common Stock

Transactions reported by MPM BIOVENTURES 2018, L.P. for Aktis Oncology, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.